VXRTライブシグナル | Getagraph.comで利益を最大化

売る 110651 min ago

@ $1.235

発行日: 13 2月 2024 @ 05:35

リターン: -42.32%

前回のシグナル: 2月 13 - 04:01

前回のシグナル: 買う

リターン: 2.06 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:47):

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform...

Stats
本日の出来高	536 735
平均出来高	1.95M
時価総額	125.96M
EPS	$0 ( 2024-03-14 )
次の収益日	( $-0.160 ) 2024-05-02
Last Dividend	$12.19 ( 2012-11-09 )
Next Dividend	$0 ( N/A )
P/E	-1.250
ATR14	$0.00100 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-28	Tucker Sean	Buy	0
2024-03-28	Tucker Sean	Sell	3 902	Common Stock
2024-03-28	Cummings James F.	Sell	3 292	Common Stock
2024-03-18	Tucker Sean	Buy	90 000	Common Stock
2024-03-18	Tucker Sean	Buy	410 000	Stock Option (right to buy)

INSIDER POWER
94.60
Last 95 transactions
Buy: 10 890 181 \| Sell: 279 805

ボリューム相関

長: 0.37 (neutral)

短: -0.27 (neutral)

Signal:(47.801) Neutral

Vaxart Inc 相関

10 最も正の相関
LYEL	0.934
LYRA	0.93
TCRT	0.92
FATE	0.92
WISA	0.915
GROM	0.914
AFMD	0.914
ARQQ	0.914
GRNA	0.913
AVO	0.912

10 最も負の相関
LRFC	-0.93
STAY	-0.928
GLLI	-0.907
IBEX	-0.905
XOMAO	-0.899
XOMAP	-0.898
CHPM	-0.898
BCOR	-0.895
MNKD	-0.893
CIIG	-0.891

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Vaxart Inc 相関 - 通貨/商品

0.00
( neutral )

0.44
( neutral )

0.00
( neutral )

-0.25
( neutral )

Vaxart Inc 財務諸表

Annual	2023
収益:	$7.38M
総利益:	$2.88M (39.02 %)
EPS:	$-0.570

FY	2023
収益:	$7.38M
総利益:	$2.88M (39.02 %)
EPS:	$-0.570

FY	2022
収益:	$107 000
総利益:	$-3.16M (-2 953.27 %)
EPS:	$-0.840

FY	2021
収益:	$892 000
総利益:	$0.00 (0.00 %)
EPS:	$-0.580

Financial Reports:

No articles found.

Vaxart Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Vaxart Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$12.19	2012-11-09
Last Dividend	$12.19	2012-11-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$12.19	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2012	$12.19	9.77%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-14.41	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.898	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-1.085	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.32	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.11	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.53	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0994	-1.500	8.34	-10.00	[0 - 0.6]
interestCoverageTTM	-57.60	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.459	2.00	-0.153	-0.306	[0 - 30]
freeCashFlowPerShareTTM	-0.471	2.00	-0.236	-0.471	[0 - 20]
debtEquityRatioTTM	0.158	-1.500	9.37	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.196	1.000	-0.0722	-0.0722	[0.2 - 0.8]
operatingProfitMarginTTM	-14.56	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-7.72	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.0623	0.800	-2.92	-2.33	[0.5 - 2]
Total Score				-1.818

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.321	1.000	-0.234	0	[1 - 100]
returnOnEquityTTM	-1.085	2.50	-8.46	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.471	2.00	-0.157	-0.471	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.459	2.00	-0.153	-0.306	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-12.31	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.59

Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.

リアルタイムの更新： Vaxart Inc [VXRT]

Upcoming Earnings Alert

Vaxart Inc Dividend Information - No Dividend Player

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)